Y. Yalcinkaya Et Al. , "The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5, 2016
Yalcinkaya, Y. Et Al. 2016. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5 .
Yalcinkaya, Y., Cinar, S., Artim-Esen, B., Kamali, S., Ocal, L., Deniz, G., ... Inanc, M.(2016). The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5.
Yalcinkaya, Yasemin Et Al. "The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5, 2016
Yalcinkaya, Yasemin Et Al. "The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5, 2016
Yalcinkaya, Y. Et Al. (2016) . "The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.5.
@article{article, author={Yasemin YALÇINKAYA Et Al. }, title={The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2016}